Abuse potential and psychoactive effects of δ-9-tetrahydrocannabinol and cannabidiol oromucosal spray (Sativex), a new cannabinoid medicine

The abuse potential of the synthetic cannabinoid nabilone

(2010) Mark A. Ware et al.   ADDICTION

P.6.c.010 Abuse potential of nabiximols oromucosal spray compared with dronabinol and placebo in recreational marijuana users

(2010) K.A. Schoedel et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

(2010) C. Collin et al.   NEUROLOGICAL RESEARCH

Emerging strategies for exploiting cannabinoid receptor agonists as medicines

(2009) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY

Pharmacotherapy for Cannabis Dependence

(2009) Ryan Vandrey et al.   CNS DRUGS

Therapeutic use ofCannabis sativaon chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis

(2008) F.C. MACHADO ROCHA et al.   EUROPEAN JOURNAL OF CANCER CARE

The endocannabinoid system as a target for the treatment of cannabis dependence

(2008) Jason R. Clapper et al.   NEUROPHARMACOLOGY

Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action

(2008) Antonio Waldo Zuardi   REVISTA BRASILEIRA DE PSIQUIATRIA

A within-subject comparison of withdrawal symptoms during abstinence from cannabis, tobacco, and both substances

(2007) R.G. Vandrey et al.   DRUG AND ALCOHOL DEPENDENCE

Cannabinoid pharmacology: the first 66 years

(2006) Roger G Pertwee   BRITISH JOURNAL OF PHARMACOLOGY